Largest pharmaceutical companies in the United States by total assets

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Pfizer leads the 44 pharmaceutical companies in the United States ranked by total assets, at NZ$379.7B, ahead of Johnson & Johnson (NZ$363.3B) and Merck & Co (NZ$249.6B). Figures as of 20 Nov 2026, 17:15 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
44
First
PfizerNZ$379.7B
Median
NZ$2.7B
Combined market value
NZ$6.86T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
NZD
Clear filters
Largest pharmaceutical companies in the United States by total assets
#CompanyTotal assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1PfizerPFE · Health CareNZ$379.7BNZ$286.7BNZ$50.29 0.13% up 10% up United States
2Johnson & JohnsonJNJ · Health CareNZ$363.3BNZ$1.19TNZ$494.02 1.39% up 31% up United States
3Merck & CoMRK · Health CareNZ$249.6BNZ$606.5BNZ$246.03 1.57% up 36% up United States
4AbbVieABBV · Health CareNZ$244.3BNZ$930.2BNZ$526.23 1.76% up 20% up United States
5Eli LillyLLY · Health CareNZ$205.1BNZ$2.2TNZ$2,470.47 0.25% up 28% up United States
6Bristol-Myers SquibbBMY · Health CareNZ$164.2BNZ$221.3BNZ$108.24 1.72% up 26% up United States
7Abbott LaboratoriesABT · Health CareNZ$158.2BNZ$329.4BNZ$190.21 0.40% up 19% down United States
8Regeneron PharmaceuticalsREGN · Health CareNZ$74BNZ$176BNZ$1,700.87 1.10% up 22% up United States
9ViatrisVTRS · Health CareNZ$67.8BNZ$40.8BNZ$35.55 1.96% down 90% up United States
10Vertex PharmaceuticalsVRTX · Health CareNZ$46.8BNZ$242.4BNZ$956.22 0.69% up 22% up United States
11Royalty PharmaRPRX · Health CareNZ$35.8BNZ$71.8BNZ$124.88 1.11% up 74% up United States
12ZoetisZTS · Health CareNZ$28.2BNZ$59.6BNZ$146.79 0.38% down 34% down United States
13Elanco Animal HealthELAN · Health CareNZ$24.4BNZ$23.5BNZ$46.95 2.09% down 18% up United States
14United TherapeuticsUTHR · Health CareNZ$14.4BNZ$43.1BNZ$1,011.93 0.77% down 18% up United States
15BioMarin PharmaceuticalBMRN · Health CareNZ$13.9BNZ$21.6BNZ$111.60 0.37% down 12% up United States
16Alnylam PharmaceuticalsALNY · Health CareNZ$9.1BNZ$36.5BNZ$272.71 1.15% up 66% down United States
17Amneal PharmaceuticalsAMRX · Health CareNZ$6.7BNZ$13.4BNZ$38.45 1.45% down 79% up United States
18Ionis PharmaceuticalsIONS · Health CareNZ$6.4BNZ$8.4BNZ$50.23 1.18% up 64% down United States
19PTC TherapeuticsPTCT · Health CareNZ$5.3BNZ$8.8BNZ$105.14 1.17% down 26% down United States
20InsmedINSM · Health CareNZ$4.1BNZ$58.6BNZ$267.21 1.42% up 27% down United States
21Legend BiotechLEGN · Health CareNZ$3.2BNZ$5.5BNZ$28.11 4.29% down 43% down United States
22Ligand PharmaceuticalsLGND · Health CareNZ$2.8BNZ$10.5BNZ$523.64 0.06% up 44% up United States
23CytokineticsCYTK · Health CareNZ$2.6BNZ$13.1BNZ$94.37 0.54% up 21% down United States
24Arrowhead PharmaceuticalsARWR · Health CareNZ$2.5BNZ$11BNZ$77.99 2.04% down 8% up United States
25Madrigal PharmaceuticalsMDGL · Health CareNZ$2.3BNZ$16.4BNZ$707.69 2.20% down 28% down United States
26TG TherapeuticsTGTX · Health CareNZ$1.9BNZ$17.8BNZ$117.82 0.43% down 103% up United States
27Praxis Precision MedicinesPRAX · Health CareNZ$1.7BNZ$15.6BNZ$558.20 1.56% down 83% up United States
28Cogent BiosciencesCOGT · Health CareNZ$1.7BNZ$8.6BNZ$49.34 2.49% down 25% down United States
29BridgeBio PharmaBBIO · Health CareNZ$1.7BNZ$27.4BNZ$140.82 1.24% down 15% up United States
30Mirum PharmaceuticalsMIRM · Health CareNZ$1.5BNZ$11.6BNZ$178.28 2.34% up 35% up United States
31Corcept TherapeuticsCORT · Health CareNZ$1.5BNZ$12.7BNZ$116.05 2.08% down 16% down United States
32Belite BioBLTE · Health CareNZ$1.4BNZ$9.6BNZ$236.66 14.08% down 25% up United States
33Spyre TherapeuticsSYRE · Health CareNZ$1.4BNZ$16.3BNZ$172.14 3.33% down 302% up United States
34Summit TherapeuticsSMMT · Health CareNZ$1.4BNZ$14.7BNZ$18.38 4.64% down 35% down United States
35Axsome TherapeuticsAXSM · Health CareNZ$1.3BNZ$12.6BNZ$239.48 3.23% down 9% down United States
36Protagonist TherapeuticsPTGX · Health CareNZ$1.2BNZ$14.6BNZ$222.99 1.42% down 45% up United States
37Travere TherapeuticsTVTX · Health CareNZ$1.1BNZ$8.4BNZ$87.86 0.27% down 39% up United States
38Edgewise TherapeuticsEWTX · Health CareNZ$1BNZ$8BNZ$73.42 2.22% down 82% up United States
39Dianthus TherapeuticsDNTH · Health CareNZ$968.3MNZ$8.6BNZ$153.49 0.80% down 105% up United States
40Oruka TherapeuticsORKA · Health CareNZ$891.2MNZ$11.7BNZ$171.83 3.44% down 233% up United States
41Rhythm PharmaceuticalsRYTM · Health CareNZ$875.8MNZ$14.2BNZ$205.53 3.52% down 15% up United States
42Definium TherapeuticsDFTX · Health CareNZ$802.7MNZ$7.2BNZ$52.85 1.71% down 176% up United States
43ErascaERAS · Health CareNZ$722.5MNZ$8.9BNZ$25.50 1.69% down 387% up United States
44VeradermicsMANE · Health CareNZ$278.4MNZ$9.2BNZ$219.05 3.45% down 230% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8239 NZD).

Questions and answers

Which pharmaceutical companies in the United States rank first by total assets?

Pfizer (NZ$379.7B), Johnson & Johnson (NZ$363.3B) and Merck & Co (NZ$249.6B) are the top three of the 44 pharmaceutical companies in the United States ranked by total assets as of 20 Nov 2026, 17:15 UTC.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by total assets.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by total assets have a combined market value of NZ$6.86T as of 20 Nov 2026, 17:15 UTC.

What does ranking by total assets measure?

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-assets

Underlying data: Yahoo Finance; SEC EDGAR.